CDC survey findings show 44% of adults reporting GLP-1 use modified their prescribed regimen, highlighting access, cost, counseling, and medication safety concerns.
In a Pharmanews interview, NAPPSA President Dr. Adekunle Tometi outlines priorities for translating health innovations into accessible care in Nigeria, including regulatory reform, manufacturing, research partnerships and responsible digital health.

